Lifecore Biomedical, Inc. \de\
LFCRNasdaqCIK 1005286HealthcareFiscal year ends May 25
Reports and events: 359 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2020:30 ET | 8-K | 8.01 Other events | 0001005286-26-000040 |
| 2026-09-2920:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-111939 |
| 2026-09-2920:12 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001005286-26-000036 |
| 2026-09-2821:41 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-26-002661 |
| 2026-09-2812:53 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-037767 |
| 2026-08-0511:20 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001005286-26-000033 |
| 2026-08-0511:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-26-000032 |
| 2026-07-0221:36 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-26-001747 |
| 2026-07-0221:17 ET | 8-K | 7.01 Regulation FD disclosure | 0001005286-26-000026 |
| 2026-07-0221:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-294951 |
| 2026-06-0520:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001005286-26-000023 |
| 2026-05-0611:22 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001005286-26-000020 |
| 2026-05-0611:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-26-000018 |
| 2026-04-2420:09 ET | DEF 14A | Proxy statementPeriod 2026-04-24 | 0001005286-26-000012 |
| 2026-03-1612:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-26-000007 |
| 2026-03-0521:33 ET | 8-K | 5.08 Item not in the standard list | 0001005286-26-000002 |
| 2026-01-1621:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-002400 |
| 2025-11-1721:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-25-000150 |
| 2025-11-0621:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001005286-25-000148 |
| 2025-11-0621:26 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-25-000146 |
| 2025-10-3120:13 ET | 8-K | 5.07 Shareholder vote results | 0001005286-25-000138 |
| 2025-09-2620:33 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001005286-25-000133 |
| 2025-09-1820:11 ET | DEF 14A | Proxy statementPeriod 2025-09-18 | 0001005286-25-000126 |
| 2025-08-1820:31 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001005286-25-000118 |
| 2025-08-1211:53 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-25-000115 |
| 2025-08-0720:38 ET | 10-K | Annual reportPeriod 2025-05-25 | 0001005286-25-000108 |
| 2025-08-0720:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001005286-25-000106 |
| 2025-07-1820:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001005286-25-000097 |
| 2025-05-2901:56 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-079298 |
| 2025-04-1620:40 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001005286-25-000072 |
| 2025-04-1020:46 ET | 8-K | 5.07 Shareholder vote results | 0001005286-25-000061 |
| 2025-04-0320:23 ET | 10-Q | Quarterly reportPeriod 2025-02-23 | 0001005286-25-000055 |
| 2025-04-0320:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-25-000052 |
| 2025-02-2721:05 ET | DEF 14A | Proxy statementPeriod 2025-02-27 | 0001005286-25-000041 |
| 2025-01-1722:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001005286-25-000028 |
| 2025-01-0714:07 ET | 8-K | 7.01 Regulation FD disclosure | 0001005286-25-000014 |
| 2025-01-0222:15 ET | 10-Q | Quarterly reportPeriod 2024-11-24 | 0001005286-25-000012 |
| 2025-01-0221:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-25-000009 |
| 2024-12-2618:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-24-140227 |
| 2024-11-2622:29 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-24-000169 |
| 2024-11-2112:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-24-000166 |
| 2024-11-0821:32 ET | 8-K | 5.07 Shareholder vote results | 0001005286-24-000163 |
| 2024-10-1020:37 ET | S-1 | Registration statement | 0001628280-24-042662 |
| 2024-10-0720:31 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-24-002253 |
| 2024-10-0411:41 ET | 10-Q | Quarterly reportPeriod 2024-08-25 | 0001005286-24-000145 |
| 2024-10-0411:36 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-24-000144 |
| 2024-09-2320:21 ET | DEF 14A | Proxy statementPeriod 2024-11-07 | 0001005286-24-000139 |
| 2024-09-2320:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list | 0001005286-24-000138 |
| 2024-09-1211:09 ET | 8-K | 8.01 Other events | 0001005286-24-000130 |
| 2024-08-2920:03 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001005286-24-000128 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.